Company intelligence / Profile preview
CSL Vifor
Sankt Gallen, Saint Gallen, Switzerlandcsl.com ↗
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Commercial
01
Overview
CSL Vifor has established itself as a global leader in the treatment of iron deficiency anemia and chronic kidney disease. Its portfolio includes several commercialized products with proven efficacy in large patient populations. The company continues to expand its reach through new indications, geographic expansion, and strategic partnerships.[1][3]
- Therapeutic areas
- CardiovascularRare DiseasesNephrologyHematology
- Modalities
- Small molecules (notably iron therapies)Biologics (select nephrology and rare disease products)In-license/partnered therapeutics[2][4]
- Industry
- Pharma
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Fresenius Medical Care – Joint venture for renal pharma products.Multiple licensing/in-license agreements for specialty nephrology/cardiology drugs.
Beyond the preview
Go deeper on CSL Vifor.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CSL Vifor.